TSW
ZYNE

Thompson Siegel & Walmsley’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,300
Closed -$157K – 786
2018
Q3 		$157K Buy
+19,300
New +$157K ﹤0.01% 416